MGRX 2.43 Mangoceuticals, Inc.
| Range: | 2.145-16.8 | Vol Avg: | 272382 | Last Div: | 0 | Changes: | -0.11 |
| Beta: | 0 | Cap: | 0.01B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Tue Mar 21 2023 | Empoloyees: | 3 | ||
| CUSIP: | 56270V106 | CIK: | 0001938046 | ISIN: | US56270V1061 | Country: | US |
| CEO: | Mr. Jacob D. Cohen | Website: | https://www.mangorx.com | ||||
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow